Qube Research & Technologies (QRT)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$69	–	4871
2023 Q3	$69	Buy	+100	New	+$128	﹤0.01%	3791
2021 Q2	–	Sell	-463	Closed	-$30K	–	2922
2021 Q1	$30K	Sell	463 -1,973	-81%	-$154K	﹤0.01%	1803
2020 Q4	$83K	Sell	2,436 -4,979	-67%	-$221K	﹤0.01%	1664
2020 Q3	$407K	Buy	7,415 +6,197	+509%	+$367K	0.01%	1115
2020 Q2	$46K	Buy	+1,218	New	+$41.7K	﹤0.01%	1611

Other funds holding DMK

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DMK Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2023, closing a stake of 100 shares — an estimated $69 sold.

Qube Research & Technologies (QRT) first reported a position in DMK in Q2 2020 and held it in 5 quarters. The position peaked at $407K in Q3 2020. 29 funds tracked by Wall St. Rank hold DMK as of Q4 2023.

Qube Research & Technologies (QRT) reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 100 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2023, an estimated $69.
Qube Research & Technologies (QRT) first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2020 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s DMK Pharmaceuticals Corporation Common Stock position peaked at $407K in Q3 2020.
29 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.